ArunA Bio Competitors and Similar CompaniesClear all

ArunA Bio's competitors and similar companies include Codiak Biosciences and Celularity.

	ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.	Celularity Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta.
Founding Date	Founding Date 2003	Founding Date 2015	Founding Date 2016
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering oncology therapy	Tags Healthcare biotech therapy	Tags Healthcare bioengineering biotech oncology therapy
Locations	Locations Athens, US HQ Athens, US	Locations Cambridge, US HQ	Locations Warren, US HQ Carlton, AU Madison, US
Employees	Employees 274% increase	Employees 992% decrease	Employees 1932% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.8 m	Valuation ($) 37.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $22.9m (FY, 2021)	Revenue (est.) $26.6m (FY, 2025)
Net income	Net income N/A	Net income ($37.2m) (FY, 2021)	Net income ($91.7m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 26.9m	Total funding raised $ 168.5m	Total funding raised $ 290m